<DOC>
	<DOCNO>NCT02780128</DOCNO>
	<brief_summary>The purpose research study match genomic aberration tumor cell time relapse rationally design combination molecularly target agent . This study do two part : Part I : Tumor access study entry via biopsy subject deep sequencing identify protocol-specified biomarkers therapy assignment . Part II : If tumor contain genetic change define study actionable , criterion meet , participant assign therapy base upon genetic change identify tumor biopsy .</brief_summary>
	<brief_title>Next Generation Personalized Neuroblastoma Therapy</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Trametinib</mesh_term>
	<mesh_term>Ceritinib</mesh_term>
	<criteria>Age &lt; 1 year old Relapsed refractory neuroblastoma A sufficient interval last dose prior anticancer therapy ( include cytotoxic biological therapy ) enrollment study , allow recovery acute toxic effect prior anticancer therapy . Please contact site specific detail Adequate bone marrow function ( bone marrow may involve tumor . Contact site specific detail ) Adequate renal function , define Creatinine clearance radioisotope glomerular filtration rate ( GFR ) ≥ 70 mL/min/1.73 m2 OR serum creatinine base age/gender normal ( contact site detail ) Adequate liver function , define total serum bilirubin 1.5 time upper limit normal AND alanine transaminase ( ALT ) ≤ 110 U/L . Adequate cardiac function , define correct QT interval ( QTc ) ≤ 480 msec AND shorten fraction &gt; 27 % Males females sexually active must agree use effective contraception 3 month treatment Subjects take certain drug herbal medication impact drug metabolism and/or cardiac function discontinue ( contact site detail ) . Subjects concurrent severe and/or uncontrolled concurrent medical condition could compromise participation study ( contact site detail ) Corticosteroids initiate tumor therapy within 7 day prior study enrollment Other anticancer agent Other investigational drug Radiation therapy Subjects &lt; 0.5m2 Pregnant lactate female Sexually active male unless use condom intercourse take study drug/s 3 month study drug discontinuation thus attempt father child period .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>neuroblastoma</keyword>
	<keyword>cancer</keyword>
	<keyword>genetic profiling</keyword>
	<keyword>ceritinib</keyword>
	<keyword>ribociclib</keyword>
	<keyword>trametinib</keyword>
	<keyword>HDM201</keyword>
</DOC>